In cancer patients at risk for VTE, DOACs are superior to heparin in preventing recurrent VTE.

Published Date: 09 Jun 2023

Direct oral anticoagulants (DOAC) were shown in a recent study by Deborah Schrag and colleagues to be noninferior to low-molecular-weight heparin (LMWH) for.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

2.

The main subject is associated with suicide in the United States.

3.

Alkem introduces cetuximab under the trade name Cetuxa in India.

4.

Firefighters who eat better can combat cancer.

5.

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot